April 21, 2025 a 01:01 pm
ISRG: Analysts Ratings - Intuitive Surgical, Inc.
Intuitive Surgical, Inc. continues to display a robust presence in the market for minimally invasive surgical technology. The company's flagship products, including the da Vinci Surgical System and Ion endoluminal system, facilitate complex procedures with precision. Recent analyst ratings reflect a generally positive sentiment, suggesting an underlying confidence in the company's technological advancements and market strategy.
Historical Stock Grades
The latest analyst ratings for Intuitive Surgical, Inc. highlight a generally positive sentiment, with a shift towards more cautious "Hold" positions compared to previous months. Below is a summary of the most recent data:
| Rating | Number | Score |
|---|---|---|
| Strong Buy | 8 | |
| Buy | 14 | |
| Hold | 10 | |
| Sell | 0 | |
| Strong Sell | 1 |
Sentiment development
Over the analyzed months, the sentiment towards Intuitive Surgical's stock has shown fluctuations. Recent data suggests:
- The number of "Strong Buy" ratings has decreased slightly, indicating a more conservative outlook.
- "Buy" ratings have remained stable, reflecting sustained confidence.
- An increase in "Hold" positions suggests caution as analysts wait for further company developments.
- "Sell" and "Strong Sell" ratings remain minimal, underscoring limited bearish sentiment.
Percentage trends
The past months have seen notable shifts in percentage terms across the analyst ratings:
- There has been a shift from "Strong Buy" to "Hold," demonstrating a cautious approach.
- "Buy" recommendations continue to represent a significant portion of overall sentiment.
- The overall distribution indicates a market awaiting further performance indicators from Intuitive Surgical, Inc.
- Notable shifts include the increased "Hold" ratings, growing from 5% to 20% over the last year.
Latest Analyst Recommendations
Recent analyst activity for Intuitive Surgical shows consistent sentiment, with maintenance of existing recommendations:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-03-18 | Outperform | Outperform | Baird |
| 2025-03-17 | Buy | Buy | Truist Securities |
| 2025-01-24 | Overweight | Overweight | Wells Fargo |
| 2025-01-24 | Overweight | Overweight | JP Morgan |
| 2025-01-24 | Overweight | Overweight | Piper Sandler |
Analyst Recommendations with Change of Opinion
Recommendations with changes in opinion highlight shifts in perspective toward Intuitive Surgical, Inc.:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2024-12-02 | Overweight | Equal Weight | Morgan Stanley |
| 2024-11-19 | Buy | Hold | Erste Group |
| 2024-08-02 | Buy | Neutral | Redburn Atlantic |
| 2022-02-02 | Buy | Neutral | UBS |
| 2022-02-01 | Buy | Neutral | UBS |
Interpretation
The overall positive sentiment indicates that Intuitive Surgical, Inc. is viewed favorably among analysts, albeit with a more cautious approach recently. The consistent maintenance of recommendations suggests stable confidence in the company's market position. However, the increase in "Hold" positions signifies a need for more clarity on future performance. The market's perception remains largely optimistic, with expectations for continued growth driven by technological advancements and broadening commercial offerings.
Conclusion
Intuitive Surgical, Inc. is positioned as a strong contender in the minimally invasive surgical technology market. Analysts' ratings reflect a cautious and balanced outlook, characterized by steady "Buy" recommendations and a moderate increase in "Hold" ratings. While capitalizing on technological prowess and strategic market expansion provides ample growth opportunities, potential risks remain, including regulatory challenges and competitive pressures. Overall, the company appears well-equipped to sustain its market leadership amidst evolving industry dynamics.